Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Canobbio

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
Cancer|April 1, 1994
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trialF Boccardo, M Pace, D Guarneri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Carboplatin in advanced hormone refractory prostatic cancer patientsL Canobbio, D Guarneri, L Miglietta, et al.
Tumori|December 31, 1984
Low-dose cisplatin and etoposide in advanced non-small cell lung carcinomaL Canobbio, A Ardizzoni, R Felletti, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alphaL Canobbio, A Rubagotti, L Miglietta, et al.
Oncology Reports|May 25, 2011
Low activity of circadian continuous fluorodeoxyuridine (fudr) chemotherapy in poor-prognosis metastatic renal-cancerL Miglietta, L Canobbio, D Cannata, et al.
Seminars in Oncology|April 1, 1995
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experienceP Fumoleau, T Delozier, J M Extra, et al.
Tumori|March 1, 1981
Hematologic parameters during treatment with high-dose medroxyprogesterone acetateF Brema, M A Queirolo, L Canobbio, et al.
Anticancer Research|November 1, 1988
Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patientsM Resasco, L Canobbio, F Trave, et al.
Cancer Treatment Reports|December 1, 1987
Doxorubicin distribution in human breast cancerC Rossi, G Gasparini, L Canobbio, et al.
Tumori|April 30, 1986
Cardiac arrhythmia: possible complication from treatment with cisplatinL Canobbio, T Fassio, G Gasparini, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Cancer|April 1, 1994
Carboplatin, methotrexate, and vinblastine in the treatment of patients with advanced urothelial cancer. A phase II trialF Boccardo, M Pace, D Guarneri, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Carboplatin in advanced hormone refractory prostatic cancer patientsL Canobbio, D Guarneri, L Miglietta, et al.
Tumori|December 31, 1984
Low-dose cisplatin and etoposide in advanced non-small cell lung carcinomaL Canobbio, A Ardizzoni, R Felletti, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-alphaL Canobbio, A Rubagotti, L Miglietta, et al.
Oncology Reports|May 25, 2011
Low activity of circadian continuous fluorodeoxyuridine (fudr) chemotherapy in poor-prognosis metastatic renal-cancerL Miglietta, L Canobbio, D Cannata, et al.
Seminars in Oncology|April 1, 1995
Vinorelbine (Navelbine) in the treatment of breast cancer: the European experienceP Fumoleau, T Delozier, J M Extra, et al.
Tumori|March 1, 1981
Hematologic parameters during treatment with high-dose medroxyprogesterone acetateF Brema, M A Queirolo, L Canobbio, et al.
Anticancer Research|November 1, 1988
Plasma retinol levels and side effects following high-dose retinyl acetate in breast cancer patientsM Resasco, L Canobbio, F Trave, et al.
Cancer Treatment Reports|December 1, 1987
Doxorubicin distribution in human breast cancerC Rossi, G Gasparini, L Canobbio, et al.
Tumori|April 30, 1986
Cardiac arrhythmia: possible complication from treatment with cisplatinL Canobbio, T Fassio, G Gasparini, et al.
Pageof 4